Urine TIMP2.IGFBP7 Reflects Kidney Injury After Moderate Volume Paracentesis in Patients With Ascites: A Randomized Control Study

IF 1.5 Q3 GASTROENTEROLOGY & HEPATOLOGY JGH Open Pub Date : 2025-04-22 DOI:10.1002/jgh3.70168
Anuchit Suksamai, Sanpolpai Khaoprasert, Amnart Chaiprasert, Sakkarin Chirapongsathorn
{"title":"Urine TIMP2.IGFBP7 Reflects Kidney Injury After Moderate Volume Paracentesis in Patients With Ascites: A Randomized Control Study","authors":"Anuchit Suksamai,&nbsp;Sanpolpai Khaoprasert,&nbsp;Amnart Chaiprasert,&nbsp;Sakkarin Chirapongsathorn","doi":"10.1002/jgh3.70168","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Urinary biomarkers may predict acute kidney injury (AKI) in cirrhosis with ascites in a moderate volume paracentesis setting.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>The study aimed to assess the risk and consequence of AKI and its progression in patients with decompensated cirrhosis undergoing paracentesis using a urine test measuring tissue inhibitor of metalloproteinases-2 (TIMP2) and insulin-like growth factor-binding protein 7 (IGFBP7).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A randomized, controlled trial was performed. All outpatients with decompensated cirrhosis with ascites and diuretic complications were enrolled and randomized into 3 and 5 L paracentesis groups. Serial urine samples were analyzed for TIMP2. IGFBP7 concentration before and after paracentesis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 90 patients with decompensated cirrhosis were consecutively enrolled during the study period. After screening, 29 patients were enrolled in the 3-L paracentesis group, and 25 patients were enrolled in the 5-L paracentesis group. The mean of the MELD score was 8 ± 1.2. Urine TIMP2.IGFBP7 &gt; 2, rising urine TIMP2, and rising urine TIMP2/urine Cr were shown in patients within the 5-L group for 48% (<i>p</i> = 0.015), 32% (<i>p</i> = 0.049), and 76% (<i>p</i> = 0.010) respectively, indicating a higher incidence of renal tubular injury markers in this group. Urine TIMP2.IGFBP7/1000 &gt; 2 was statistically significant to predict a hemodynamic event (<i>p</i> = 0.002).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In cirrhotic patients with ascites undergoing paracentesis, a 5-L paracentesis volume was associated with a higher incidence of renal tubular injury markers.</p>\n \n <p><b>Trail Registration:</b> The national clinical registration number was TCTR20191116003.</p>\n </section>\n </div>","PeriodicalId":45861,"journal":{"name":"JGH Open","volume":"9 4","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgh3.70168","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JGH Open","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jgh3.70168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Urinary biomarkers may predict acute kidney injury (AKI) in cirrhosis with ascites in a moderate volume paracentesis setting.

Objective

The study aimed to assess the risk and consequence of AKI and its progression in patients with decompensated cirrhosis undergoing paracentesis using a urine test measuring tissue inhibitor of metalloproteinases-2 (TIMP2) and insulin-like growth factor-binding protein 7 (IGFBP7).

Methods

A randomized, controlled trial was performed. All outpatients with decompensated cirrhosis with ascites and diuretic complications were enrolled and randomized into 3 and 5 L paracentesis groups. Serial urine samples were analyzed for TIMP2. IGFBP7 concentration before and after paracentesis.

Results

A total of 90 patients with decompensated cirrhosis were consecutively enrolled during the study period. After screening, 29 patients were enrolled in the 3-L paracentesis group, and 25 patients were enrolled in the 5-L paracentesis group. The mean of the MELD score was 8 ± 1.2. Urine TIMP2.IGFBP7 > 2, rising urine TIMP2, and rising urine TIMP2/urine Cr were shown in patients within the 5-L group for 48% (p = 0.015), 32% (p = 0.049), and 76% (p = 0.010) respectively, indicating a higher incidence of renal tubular injury markers in this group. Urine TIMP2.IGFBP7/1000 > 2 was statistically significant to predict a hemodynamic event (p = 0.002).

Conclusion

In cirrhotic patients with ascites undergoing paracentesis, a 5-L paracentesis volume was associated with a higher incidence of renal tubular injury markers.

Trail Registration: The national clinical registration number was TCTR20191116003.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
尿液中的 TIMP2.IGFBP7 可反映腹水患者适量腹腔穿刺术后的肾损伤:随机对照研究
背景 尿液生物标志物可预测中等容量腹腔穿刺术中肝硬化腹水患者的急性肾损伤(AKI)。 目的 该研究旨在通过尿液检测组织金属蛋白酶抑制剂-2(TIMP2)和胰岛素样生长因子结合蛋白 7(IGFBP7),评估接受腹腔穿刺术的失代偿期肝硬化患者发生 AKI 及其进展的风险和后果。 方法 进行了一项随机对照试验。所有患有失代偿期肝硬化并伴有腹水和利尿并发症的门诊患者均被纳入试验,并随机分为 3 升腹腔穿刺组和 5 升腹腔穿刺组。对连续尿液样本进行 TIMP2 分析。腹腔穿刺前后的 IGFBP7 浓度。 结果 在研究期间,共有 90 名失代偿期肝硬化患者连续入组。经过筛选,29 名患者被纳入 3 升腹腔穿刺术组,25 名患者被纳入 5 升腹腔穿刺术组。MELD 评分的平均值为 8 ± 1.2。尿TIMP2.IGFBP7 >2、尿TIMP2升高、尿TIMP2/尿Cr升高在5L组患者中分别占48%(P = 0.015)、32%(P = 0.049)和76%(P = 0.010),表明该组肾小管损伤标志物的发生率更高。尿液中的 TIMP2.IGFBP7/1000 > 2 在预测血流动力学事件方面具有统计学意义(p = 0.002)。 结论 在接受腹腔穿刺术的肝硬化腹水患者中,5 升腹腔穿刺量与较高的肾小管损伤指标发生率相关。 追踪登记:国家临床注册号为 TCTR20191116003。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JGH Open
JGH Open GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
3.40
自引率
0.00%
发文量
143
审稿时长
7 weeks
期刊最新文献
The Impact of Hiatus Hernia Size on Dysplasia Progression in Patients With Barrett's Esophagus. Unspecific Findings of Oropharyngeal and Esophageal Dysmotility During Solid Bolus Swallowing. Rise in Admissions for Acute Severe Ulcerative Colitis at an Australian Health Service With a Culturally and Linguistically Diverse Population. Progress in Gastroparesis Management: From Pharmacotherapy to Interventional Treatments. Factors Associated With Loss of Fecal Biomarker Accuracy During Routine Assessment of Inflammatory Bowel Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1